FundedIQ
Biotechnology

Thetis Pharmaceuticals: Funding, Investors & Team (Oct 2026)

Thetis Pharmaceuticals LLC is a biopharmaceutical company developing novel small molecule drugs to treat inflammatory diseases.

thetispharma.com LinkedIn Ridgefield, United States 1-10 employees
Biotechnology Clinical Trials Medical Pharmaceutical
Total raised
$13.2M
Rounds
2
Latest
Undisclosed round
Jan 2025

Thetis Pharmaceuticals has raised $13.2M across 2 funding rounds on record, the most recent an undisclosed round of $9.0M announced in Jan 2025.

That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Thetis Pharmaceuticals Company Profile and Key Stats

Total funding raised
$13.2M
across 2 rounds on record
Funding rounds on record
2
Latest funding round
Undisclosed round
$9.0M in Jan 2025
Employees
1-10
reported band
Headquarters
Ridgefield, United States

Latest funding round on record: Jan 2025.

Thetis Pharmaceuticals Funding Rounds

Date
Round
Amount
Undisclosed round
$9.0M
Grant
$4.2M

Thetis Pharmaceuticals raised $4.2M in a Grant announced in Apr 2022.

2.8 years later, an undisclosed round of $9.0M was announced in Jan 2025.

Thetis Pharmaceuticals Founders and Leadership Team

Name
Role
Contact
Gary Mathias
Founder
Locked

Contact details for the Thetis Pharmaceuticals team: 1 of 1 has an email address on file.

Start 14-day free trial →

Thetis Pharmaceuticals Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.1M
30,148
$7.5M

Thetis Pharmaceuticals' latest round of $9.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Thetis Pharmaceuticals in Biotechnology and Ridgefield

Companies Similar to Thetis Pharmaceuticals

Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…

Undisclosed round $94.0M

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…

Series B $9.5M

Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…

Series B $33.0M

Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…

Undisclosed round —

Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.

Series A $15.0M

Serán is a contract development and manufacturing organization providing a comprehensive suite of…

Private Equity —

Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…

Series D $250M

Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…

Series E $311M

Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…

Undisclosed round $8.5M

Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…

Series E $92.5M

Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…

Series B $40.0M

Datavant is a developer of a healthcare data platform dedicated to assisting in protecting, matching, and…

Private Equity —

Thetis Pharmaceuticals Funding FAQs

What does Thetis Pharmaceuticals do?

Thetis Pharmaceuticals LLC is a biopharmaceutical company developing novel small molecule drugs to treat inflammatory diseases.

How much funding has Thetis Pharmaceuticals raised?

Thetis Pharmaceuticals has raised $13.2M across 2 rounds on record. The most recent is an undisclosed round of $9.0M announced in Jan 2025.

When did Thetis Pharmaceuticals last raise funding?

Thetis Pharmaceuticals' most recent funding round on record is an undisclosed round of $9.0M, announced in Jan 2025.

Who founded Thetis Pharmaceuticals?

FundedIQ lists Gary Mathias (Founder) at Thetis Pharmaceuticals.

Where is Thetis Pharmaceuticals headquartered?

Thetis Pharmaceuticals is based in Ridgefield, Connecticut, United States.

How many employees does Thetis Pharmaceuticals have?

Thetis Pharmaceuticals is in the 1-10 employee band.

How does Thetis Pharmaceuticals' funding compare to other Biotechnology startups?

Thetis Pharmaceuticals' latest round of $9.0M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's Thetis Pharmaceuticals Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Thetis Pharmaceuticals is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.